ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,182Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1006

$1.05M Total Retail Price of All Prescriptions

Rank: 37 out of 1006

499 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 14,991 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 902 850 1 8
FUROSEMIDE 573 531 2 6
METOPROLOL TARTRATE 556 522 3 7
LEVOTHYROXINE SODIUM 476 450 4 2
SIMVASTATIN 453 435 5 1
LISINOPRIL 446 404 6 3
AMLODIPINE BESYLATE 426 413 7 4
DONEPEZIL HCL 365 363 8 17
ATORVASTATIN CALCIUM 360 318 9 5
HYDROCODONE-ACETAMINOPHEN 317 246 S3 10 25
NAMENDA 228 226 11 34
METFORMIN HCL 227 214 12 10
TRAZODONE HCL 212 210 13 21
OMEPRAZOLE 207 207 14 9
MIRTAZAPINE 203 199 15 26
ATENOLOL 199 187 16 13
ESCITALOPRAM OXALATE 181 175 17 27
POTASSIUM CHLORIDE 179 173 18 30
CYMBALTA 177 167 19 41
LANTUS 174 138 20 43
METOPROLOL SUCCINATE 170 161 21 12
GABAPENTIN 164 153 22 20
IPRATROPIUM-ALBUTEROL 159 153 23 73
TAMSULOSIN HCL 145 138 24 23
PREDNISONE 145 141 24 33
SERTRALINE HCL 141 123 26 19
DIOVAN 139 136 27 16
CARVEDILOL 136 125 28 36
CRESTOR 131 111 29 18
HYDROCHLOROTHIAZIDE 129 114 30 11
LOSARTAN POTASSIUM 125 123 31 22
CITALOPRAM HBR 124 118 32 24
QUETIAPINE FUMARATE 121 121 33 45
ALLOPURINOL 120 120 34 31
CLOPIDOGREL 112 101 35 46
DIVALPROEX SODIUM 112 95 35 53
NOVOLOG 108 66 37 94
ZOLPIDEM TARTRATE 106 104 38 14
OXYBUTYNIN CHLORIDE ER 106 106 38 92
DIGOXIN 99 99 40 52
ISOSORBIDE MONONITRATE ER 96 96 41 59
FAMOTIDINE 96 96 41 110
METHOCARBAMOL 92 55 R 43 225
PRAVASTATIN SODIUM 90 90 44 15
PANTOPRAZOLE SODIUM 88 78 45 32
GLIMEPIRIDE 83 78 46 50
RANITIDINE HCL 81 68 47 63
SEROQUEL 80 80 48 97
ALENDRONATE SODIUM 80 80 48 29
NEXIUM 79 79 50 28
FINASTERIDE 78 73 51 76
ROPINIROLE HCL 76 76 52 154
SPIRIVA 72 72 53 48
TRAMADOL HCL 71 71 54 35
CARBIDOPA-LEVODOPA 69 69 55 80
LIPITOR 68 54 56 47
HYDROMORPHONE HCL 67 67 S2 57 153
LEXAPRO 66 63 58 103
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 59 77
TAMIFLU 62 60 60 236
OXYCODONE-ACETAMINOPHEN 61 30 S2 61 57
LEVETIRACETAM 61 49 61 72
FLUOXETINE HCL 60 60 63 85
FENTANYL 60 36 S2 63 74
PLAVIX 60 58 63 61
SYNTHROID 60 60 63 42
DILTIAZEM 24HR CD 59 59 67 88
OXYBUTYNIN CHLORIDE 57 57 68 197
HYDRALAZINE HCL 57 57 68 100
KLOR-CON M20 56 32 70 70
VENLAFAXINE HCL 55 55 71 249
PAROXETINE HCL 55 55 71 62
LIDODERM 54 54 73 66
ALBUTEROL SULFATE 54 51 73 155
HUMALOG 54 52 73 116
PROCHLORPERAZINE MALEATE 54 46 73 234
ACTONEL 53 53 77 152
BENICAR 53 41 77 78
CIPROFLOXACIN HCL 52 49 79 75
CLOTRIMAZOLE-BETAMETHASONE 51 50 80 111
ADVAIR DISKUS 51 49 80 37
RISPERIDONE 50 42 82 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.